Minerals

Your Ferritin Is Low — That's Why Your Hair Is Falling Out

Iron deficiency is the most common nutritional deficiency worldwide — and one of the least recognized drivers of chronic hair shedding. You can have normal hemoglobin and still be losing hair because your ferritin is low. Understanding the biochemistry behind iron and follicle function reveals why standard blood panels often miss the problem entirely.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
iron deficiencyhair lossferritintelogen effluviumzincpostpartum hair loss
Your Ferritin Is Low — That's Why Your Hair Is Falling Out

Tracing the Biochemistry of Iron for Hair Loss

Hair loss is rarely just cosmetic. When strands accumulate on your brush, your pillow, or the shower drain, your body is communicating something deeper about its internal resource allocation. Among all nutritional deficiencies linked to hair thinning, iron depletion is the most prevalent and, paradoxically, the most frequently overlooked — particularly in premenopausal women, vegans, and endurance athletes.

This article traces the precise biochemical pathway from iron depletion to follicle miniaturization, examines the clinical evidence, and explains what the optimal intervention actually looks like — including how a personalized formula can address the full cascade rather than just the mineral in isolation.

---

Why the Hair Follicle Is Uniquely Vulnerable to Iron Deficiency

The hair follicle matrix is one of the most rapidly dividing cell populations in the human body. Matrix keratinocytes divide every 12–24 hours, a rate that demands enormous quantities of DNA synthesis cofactors — and iron is at the center of that demand.

Iron is an essential cofactor for ribonucleotide reductase, the enzyme responsible for synthesizing deoxyribonucleotides (the building blocks of DNA). Without adequate iron, this enzyme cannot sustain the replication velocity that the follicle requires during anagen (growth phase). The follicle responds by shortening the anagen phase and prematurely entering catagen (regression), ultimately producing thinner, shorter telogen hairs — the clinical picture of telogen effluvium.

Beyond DNA synthesis, iron is required for:

  • Cytochrome c oxidase activity — the mitochondrial enzyme complex driving ATP production in follicle cells
  • Ferroportin-mediated iron export in the follicle dermal papilla, where iron homeostasis signals interact with hepcidin
  • Thyroid peroxidase function — the enzyme that synthesizes T3/T4, and whose activity drops when iron is depleted, creating a secondary pathway to hair loss through hypothyroid-pattern shedding
  • Collagen prolyl hydroxylase — an iron-dependent enzyme required for the structural collagen scaffold of the follicle bulb

This multi-pathway vulnerability explains why iron deficiency hair loss is notoriously resistant to topical treatments alone. You cannot fix a substrate deficiency from the outside.

---

Does Iron Help With Hair Loss? What the Clinical Evidence Shows

The clinical picture here is more nuanced than a simple yes or no. Let's parse the evidence carefully.

A pivotal review by Rushton (2002) in Clinical and Experimental Dermatology identified iron deficiency as a primary modifiable cause of diffuse telogen hair loss in women, noting that serum ferritin below 40 µg/L was associated with impaired hair cycling even in the absence of frank anemia (PMID: 12000632). This threshold — 40 µg/L — is substantially higher than the conventional anemia cutoff of 12–15 µg/L, which is why many patients are told their iron is "normal" while their follicles are still under-resourced.

A double-blind, randomized controlled trial by Kantor et al. published in the Journal of Investigative Dermatology (2003) found that women with diffuse hair loss had significantly lower ferritin levels than controls (mean 27.9 vs. 43.5 µg/L), with the correlation holding independent of hemoglobin (PMID: 12787139). The study reinforced that stored iron — not circulating iron — is the operative biomarker.

More recently, a 2013 systematic review in the Journal of the American Academy of Dermatology examined the relationship between iron status and nonscarring alopecia across multiple hair loss patterns, concluding that evidence supports iron repletion as a therapeutic strategy in patients with low ferritin, particularly for telogen effluvium and female-pattern hair loss (PMID: 22921771).

The practical clinical threshold supported by dermatological literature is a ferritin target of 70–100 µg/L for hair regrowth optimization, not the anemia prevention threshold of 12–15 µg/L. This is a critical distinction that most primary care panels miss.

---

The Ferritin Threshold: Why Standard Lab Ranges Mislead You

Lab reference ranges are built around population averages, not optimal function. A ferritin of 15 µg/L is technically "within range" at most commercial labs, but it represents a body operating with near-depleted iron stores — the biological equivalent of a car with a warning light on. For hair follicles, that warning light means compromised matrix cell division.

Here is a practical framework for interpreting ferritin in the context of hair health:

Ferritin LevelIron Store StatusHair Loss RiskClinical Action
< 15 µg/LDepletedSevereIron supplementation + investigate cause
15–40 µg/LLow-normalModerate-HighSupplementation + dietary optimization
40–70 µg/LAdequateModerateDietary iron + cofactor support
70–100 µg/LOptimal for hairLowMaintenance + monitor
> 100 µg/LRepletion rangeLowMaintenance

Important caveat: ferritin is an acute phase reactant, meaning it rises during infection or inflammation. A ferritin of 80 µg/L in someone with active systemic inflammation may not accurately reflect true iron stores. A complete picture includes serum iron, TIBC (total iron binding capacity), transferrin saturation, and a CBC — not just ferritin in isolation.

This is precisely where AI-driven health platforms have a real advantage. Rather than reading one marker in isolation, Ones analyzes uploaded blood panels holistically — ferritin alongside transferrin saturation, TIBC, hemoglobin, and hsCRP — to determine whether iron support is warranted and at what dose, rather than applying a generic protocol to every user.

---

Iron on Empty Stomach: Absorption Optimization and Tolerability

Assuming supplementation is warranted, how you take iron matters enormously. Iron absorption is a tightly regulated, competitive process.

Non-heme iron (the form in most supplements) is absorbed via the divalent metal transporter 1 (DMT1) in duodenal enterocytes. This process is:

  • Enhanced by vitamin C (ascorbic acid), which reduces ferric Fe³⁺ to the absorbable ferrous Fe²⁺ form
  • Inhibited by calcium, polyphenols (coffee, tea), phytates (grains, legumes), and certain medications (antacids, PPIs)

Taking iron on an empty stomach maximizes absorption — studies show that fasted administration increases non-heme iron bioavailability by approximately 40% compared to administration with food (Hallberg et al., Acta Medica Scandinavica, 1989 — a foundational study in iron bioavailability research). However, GI side effects (nausea, constipation, cramping) are significantly more common on an empty stomach.

A pragmatic middle-ground protocol endorsed by several clinical guidelines:

  1. Take iron with a small amount of vitamin C (250–500 mg ascorbic acid) but without major food
  2. Avoid coffee, tea, or calcium-rich foods within 2 hours of dosing
  3. If GI tolerability is an issue, switch to iron bisglycinate (a chelated form with superior tolerability and comparable absorption to ferrous sulfate)
  4. Consider alternate-day dosing — a 2017 study in The Lancet Haematology found that alternate-day iron supplementation produced higher fractional absorption than daily dosing by allowing hepcidin levels to reset between doses (PMID: 28065739)

For individuals with sensitive GI tracts or those on restrictive diets, iron bisglycinate at 25–36 mg elemental iron on alternate days represents a well-tolerated, evidence-supported protocol.

---

Best Zinc for Hair Loss: The Iron–Zinc Synergy You Can't Ignore

Any complete discussion of iron and hair loss must address zinc, because these two minerals compete for the same intestinal absorptive transporters (DMT1 and ZIP4). High-dose iron supplementation can meaningfully suppress zinc absorption — and zinc deficiency independently drives hair loss through a separate but overlapping pathway.

Zinc is required for:

  • 5-alpha-reductase regulation in the follicle (relevant to androgenetic alopecia)
  • Keratin protein synthesis via zinc-finger transcription factors
  • Follicular IGF-1 signaling, which maintains anagen phase duration

A placebo-controlled trial published in Annals of Dermatology (2013) found that oral zinc gluconate supplementation significantly reduced hair loss scores in patients with telogen effluvium and low zinc levels (PMID: 23717139).

The best zinc forms for hair support, ranked by bioavailability: zinc bisglycinate > zinc picolinate > zinc citrate > zinc gluconate > zinc oxide. Zinc oxide has poor bioavailability and is best avoided. For most adults, 15–30 mg elemental zinc per day is the therapeutic range — adequate to support follicle function without inducing copper deficiency (which can occur with chronic high-dose zinc).

For a deeper look at zinc dosing and its role across hair and immune function, the evidence base for zinc in androgenetic alopecia is worth reviewing alongside this article.

When building a formula that includes iron support, the ideal approach balances both minerals: sufficient iron to reach the 70–100 µg/L ferritin target without overshooting zinc depletion. This is not a calculation most people can do themselves — it requires knowing baseline serum levels of both minerals before dosing.

---

Iron for Pregnancy: Elevated Requirements and Hair Loss Connections

Pregnancy and the postpartum period represent the highest-demand scenario for iron in the human lifecycle. Blood volume expands by approximately 40–50% during pregnancy, while red cell mass increases by only 20–30%, creating a dilutional effect that dramatically increases iron requirements.

The WHO recommends 30–60 mg elemental iron daily during pregnancy, and the American College of Obstetricians and Gynecologists (ACOG) supports routine iron supplementation for all pregnant individuals beginning in the first trimester. Failure to meet these demands increases risk for:

  • Iron deficiency anemia (IDA), affecting 38% of pregnancies globally per WHO estimates
  • Low birth weight and preterm delivery
  • Postpartum hair loss — one of the most common complaints in the 3–6 months following delivery

Postpartum telogen effluvium is driven by two compounding factors: the dramatic hormonal shift after delivery (estrogen withdrawal) and the iron depletion that accumulated during gestation. Ferritin levels commonly bottom out at 6–8 weeks postpartum, precisely when postpartum shedding peaks.

If you're navigating postpartum recovery or planning a pregnancy, reading about iron and nutrient needs during pregnancy alongside your OB's guidance will give you a clearer biochemical picture of what your body is managing.

For postpartum hair loss specifically, the intervention window is: recheck ferritin at 6–8 weeks postpartum, target repletion to 70+ µg/L, and maintain adequate zinc and B-complex (particularly biotin-adjacent B vitamins like folate and B12) to support the rebuilding anagen phase.

---

What This Means for Your Formula

Because iron, zinc, thyroid function, and cellular energy metabolism are so tightly interwoven in hair follicle biology, the most effective supplement approach addresses multiple nodes of this network simultaneously — not just iron in isolation.

Here's how Ones approaches this systematically:

Iron (as Bisglycinate): Ones sources iron in the bisglycinate chelate form for superior GI tolerability and absorption. Dosing is calibrated from uploaded lab data — Ones won't include iron if ferritin is already at optimal levels, avoiding the risk of excess. Target repletion range is individualized to the user's baseline ferritin and transferrin saturation.

Zinc (Bisglycinate, 15–30 mg elemental): Ones includes zinc in bisglycinate form — the highest bioavailability zinc chelate — at doses matched to serum zinc levels. For users supplementing iron, the formula accounts for competitive absorption dynamics and ensures zinc is not being suppressed.

Thyroid Support Blend: Because iron depletion compromises thyroid peroxidase function, Ones includes its Thyroid Support System Blend for users whose labs or health history suggest thyroid-follicle axis involvement. This blend combines selenomethionine, iodine, and supporting cofactors that reinforce TPO activity, addressing the secondary pathway by which iron deficiency translates to hypothyroid-pattern hair loss.

For users whose hair loss pattern also involves elevated cortisol (common in postpartum and high-stress populations), clinical evidence for ashwagandha in cortisol reduction is worth exploring — KSM-66 Ashwagandha at 600 mg is included in Ones formulas where adrenal dysregulation is flagged by wearable or lab data.

The 6, 9, or 12-capsule plan structure means Ones can accommodate iron bisglycinate, zinc bisglycinate, thyroid support, and additional actives (like Vitamin D3 + K2, which influences hair follicle cycling through VDR signaling) without exceeding a sensible daily capsule load. The formula is built from your actual numbers — not a generic "hair support" stack.

---

Key Takeaways

  • Ferritin is the operative biomarker for iron-related hair loss — not hemoglobin. Target 70–100 µg/L for hair regrowth, not just the anemia prevention cutoff of 12–15 µg/L.
  • Iron supports hair growth through at least four biochemical pathways: DNA synthesis (ribonucleotide reductase), mitochondrial ATP production, thyroid hormone synthesis, and follicle collagen scaffolding.
  • Taking iron on an empty stomach maximizes absorption but reduces tolerability. Iron bisglycinate on alternate days with vitamin C is a well-supported compromise strategy.
  • Zinc is a critical co-intervention — high-dose iron can suppress zinc absorption, and zinc independently regulates follicle growth. Balance both minerals based on your lab values.
  • Postpartum iron depletion compounds hormonal shedding and is a primary driver of postpartum telogen effluvium; recheck ferritin at 6–8 weeks postpartum.
  • Personalized formulas outperform generic protocols — because iron, zinc, thyroid function, and vitamin D status are interdependent, a formula calibrated to your specific labs addresses the full cascade rather than one node in isolation.

Always consult a qualified healthcare provider before starting iron supplementation, particularly if you have hemochromatosis, inflammatory bowel disease, or are currently pregnant.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading